Clinical Trials Arena on MSN3d
Vividion begins subject dosing in trial of RAS-driven cancer treatment
The therapy is the fourth clinical-stage programme derived from the company’s chemoproteomics discovery platform.
Managed Healthcare Executive3d
FDA Grants Accelerated Approval to Vanrafia for IgAN, a Rare Kidney Disease
Vanrafia reduces proteinuria in adults with primary immunoglobulin A nephropathy (IgAN). It has a wholesale acquisition cost ...
Zacks Investment Research on MSN3d
SNY's Rilzabrutinib Gets FDA's Orphan Drug Tag for Two Rare Diseases
Sanofi SNY announced that the FDA has granted orphan drug designation to its investigational BTK inhibitor, rilzabrutinib, ...
USTR flags barriers for med device export to India ahead of Apr 2 deadline
Ahead of the April 2 rollout of its reciprocal tariff plan, the United States Trade Representative (USTR) has raised concerns ...